DOCSLIB.ORG
  • Sign Up
  • Log In
  • Upload
  • Sign Up
  • Log In
  • Upload
  • Home
  • »  Tags
  • »  Enalaprilat

Enalaprilat

  • The Direct Effects of the Angiotensin-Converting Enzyme

    The Direct Effects of the Angiotensin-Converting Enzyme

  • Angiotensin-Converting Enzyme (ACE) Inhibitors

    Angiotensin-Converting Enzyme (ACE) Inhibitors

  • Lisinopril (Ethics) Lisinopril Tablets 5 Mg, 10 Mg, 20 Mg

    Lisinopril (Ethics) Lisinopril Tablets 5 Mg, 10 Mg, 20 Mg

  • Enalaprilat Injection Has Been Used Concomitantly with Digitalis, Beta

    Enalaprilat Injection Has Been Used Concomitantly with Digitalis, Beta

  • Different Effects of Imidapril and Enalapril on Aminopeptidase P Activity in the Mouse Trachea

    Different Effects of Imidapril and Enalapril on Aminopeptidase P Activity in the Mouse Trachea

  • July-August 2010 Volume 32 No

    July-August 2010 Volume 32 No

  • Aliskiren, a Novel Oral Renin Inhibitor, Provides Dose-Dependent Efficacy and Placebo-Like Tolerability in Japanese Patients

    Aliskiren, a Novel Oral Renin Inhibitor, Provides Dose-Dependent Efficacy and Placebo-Like Tolerability in Japanese Patients

  • Potential Chemical Contaminants in the Marine Environment

    Potential Chemical Contaminants in the Marine Environment

  • Beta Blocker and Blood Pressure Medication Guidelines

    Beta Blocker and Blood Pressure Medication Guidelines

  • Pharmachologic Treatment of Hypertension

    Pharmachologic Treatment of Hypertension

  • AHRQ%Systematic%Review%Surveillance% Program%

    AHRQ%Systematic%Review%Surveillance% Program%

  • Beta Blockers and Blood Pressure Medication Guidelines 11/2014

    Beta Blockers and Blood Pressure Medication Guidelines 11/2014

  • Angiotensin Converting Enzyme (ACE)

    Angiotensin Converting Enzyme (ACE)

  • Annual Review of Antihypertensives - Fiscal Year 2009 Oklahoma Healthcare Authority April 2010

    Annual Review of Antihypertensives - Fiscal Year 2009 Oklahoma Healthcare Authority April 2010

  • ACE2 As a Potential Therapeutic Target for Pandemic COVID-19 Cite This: RSC Adv., 2020, 10,39808 Bhaswati Chatterjee *A and Suman S

    ACE2 As a Potential Therapeutic Target for Pandemic COVID-19 Cite This: RSC Adv., 2020, 10,39808 Bhaswati Chatterjee *A and Suman S

  • Comparison of Approved Ace Inhibitors

    Comparison of Approved Ace Inhibitors

  • The Renin-Angiotensin Pathway

    The Renin-Angiotensin Pathway

  • African Countries

    African Countries

Top View
  • The Effect of Candesartan on the Pharmacokinetics of Enalaprilat in Nephrotic Rats
  • New Zealand Data Sheet
  • Angiotensin Converting Enzyme (Ace) Inhibitors
  • Timed Inhibition of the Renin-Angiotensin System Suppresses the Rise in Blood Pressure Upon Awakening in Spontaneously
  • Completing the Enalaprilat Excretion Pathway—Renal Handling by the Proximal Tubule
  • Renin Inhibition: What Are the Therapeutic Opportunities?
  • 2018 Preventive Generics Drug List
  • Supplement 1: Nephrotoxic Or Renally Eliminated Medications That Trigger
  • Impact of the Renin-Angiotensin- Aldosterone System on Blood Pressure Response to Intravenous Enalaprilat in Patients with Hypertensive Crises
  • Renal Interstitial Fluid Angiotensin I and Angiotensin II Concentrations During Local Angiotensin-Converting Enzyme Inhibition
  • [Product Monograph Template
  • Enalapril Maleate)
  • 208686Orig1s000
  • [Product Monograph Template
  • DIABETES YOUR TAKE CONTROL GUIDE Medications
  • Searching for Pharmacophores in Large Coordinate Data Bases and Its Use in Drug Design (Topographic/Three-Dimensional Substructure/Concord) ROBERT P
  • Redalyc.Renin Inhibitors As Antihypertensive Agents


© 2024 Docslib.org    Feedback